Information Provided By:
Fly News Breaks for July 13, 2017
ABT, DXCM
Jul 13, 2017 | 09:52 EDT
Jefferies analyst Raj Denhoy says that in a surprise move, Bigfoot Biomedical selected Abbott's (ABT) FreeStyle Libre as the continuous glucose monitor for its diabetes management system over Dexcom (DXCM) and others. The selection of Abbott is an endorsement of the company's "simplicity over point accuracy," the analyst contends. Shares of Dexcom (DXCM) are down 3% to $69.92 in early trading.
News For DXCM;ABT From the Last 2 Days
There are no results for your query DXCM;ABT